Enoxaparin and Antifactor Xa Levels in Acute Burn PatientsLIN, Hsin; FARAKLAS, Iris; COCHRAN, Amalia et al.Journal of burn care & research. 2011, Vol 32, Num 1, pp 1-5, issn 1559-047X, 5 p.Article

Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparinSIMONS, R; MALLETT, S. V.Anaesthesia. 2007, Vol 62, Num 11, pp 1175-1178, issn 0003-2409, 4 p.Article

The effect of low molecular weight heparin (enoxaparin) on enhanced coagulation induced by crystalloid haemodilutionLLEWELLYN, R. L; JAMES, M. F. M.Anaesthesia. 2010, Vol 65, Num 10, pp 1013-1016, issn 0003-2409, 4 p.Article

Enoxaparin as bridging anticoagulant treatment in cardiac surgeryRLIVAS-GANDARA, N; FERREIRA-GONZALEZ, I; TORNOS, P et al.Heart (London 1996). 2008, Vol 94, Num 2, pp 205-210, issn 1355-6037, 6 p.Article

Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assayKATRANCIOGLU, Nurkay; KARAHAN, Oguz; TURHAN KILIC, Ahmet et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 3, pp 218-221, issn 0957-5235, 4 p.Article

Enoxaparin Anticoagulation Monitoring in the Catheterization Laboratory Using a New Bedside TestSILVAIN, Johanne; BEYGUI, Farzin; COLLET, Jean-Philippe et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 7, pp 617-625, issn 0735-1097, 9 p.Article

Individualized Compared With Conventional Dosing of EnoxaparinBARRAS, M. A; DUFFULL, S. B; ATHERTON, J. J et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 6, pp 882-888, issn 0009-9236, 7 p.Article

Generic low-molecular-weight heparins: Some practical considerationsFAREED, Jawed; LEONG, Wendy L; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 703-713, issn 0094-6176, 11 p.Conference Paper

Patch-test positivity in cutaneous reactions to enoxaparinENRIQUE, E; ALIJOTAS, J; CISTERO, A et al.Contact dermatitis. 2000, Vol 42, Num 1, issn 0105-1873, p. 43Article

Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjectsZAHIR, Hamim; MATSUSHIMA, Nobuko; HALIM, Abdel-Baset et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 166-175, issn 0340-6245, 10 p.Article

Timing of postpartum enoxaparin administration and severe postpartum hemorrhageFREEDMAN, Rachel A; BAUER, Kenneth A; NEUBERG, Donna S et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 1, pp 55-59, issn 0957-5235, 5 p.Article

Assessment of Bleeding Events Associated With Short-Duration Therapeutic Enoxaparin Use in the Morbidly ObeseHAGOPIAN, Jennifer C; RINEY, Jennifer N; HOLLANDS, James M et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 12, pp 1641-1648, issn 1060-0280, 8 p.Article

Outcomes in mice with abdominal angiostrongyliasis treated with enoxaparinRODRIGUEZ, Rubens; MACHADO PORTO, Sérgio; DOS SANTOS FERRARI, Rodrigo et al.Parasitology research (1987). 2011, Vol 109, Num 3, pp 787-792, issn 0932-0113, 6 p.Article

Investigation of Freezing-and Thawing-Induced Biological, Chemical, and Physical Changes to Enoxaparin SolutionPATEL, Rahul P; NARKOWICZ, Christian; JACOBSON, Glenn A et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 3, pp 1118-1128, issn 0022-3549, 11 p.Article

Investigation of the Effect of Heating on the Chemistry and Antifactor Xa Activity of EnoxaparinPATEL, Rahul P; NARKOWICZ, Christian; JACOBSON, Glenn A et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 5, pp 1700-1711, issn 0022-3549, 12 p.Article

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparinMOUSA, Shaker A; LINHARDT, Robert; FRANCIS, John L et al.Thrombosis and haemostasis. 2006, Vol 96, Num 6, pp 816-821, issn 0340-6245, 6 p.Article

Dose response of enoxaparin at the cremaster muscle flap microcirculationERTAS, Nilgün Markal; GOLDMAN, Corey; DEITCHER, Steven et al.Microsurgery. 2005, Vol 25, Num 2, pp 147-151, issn 0738-1085, 5 p.Article

Validation of the anti-factor Xa assay for the potency assessment of enoxaparin in pharmaceutical formulationsLUIZ DALMORA, Sérgio; BRUM JUNIOR, Liberato; SCHMIDT, Cleber Alberto et al.Journal of AOAC International. 2004, Vol 87, Num 6, pp 1305-1308, issn 1060-3271, 4 p.Article

Enoxaparin-induced generalized exanthemKIM, Karen H; LYNFIELD, Yelva.Cutis (New York, NY). 2003, Vol 72, Num 1, pp 57-60, issn 0011-4162, 4 p.Article

A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the Evaluating Enoxaparin Clotting Times (ELECT) StudyMOLITERNO, David J; HERMILLER, James B; LEVINE, Glenn N et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 6, pp 1132-1139, issn 0735-1097, 8 p.Article

Optimal strategy for administering Enoxaparin to patients undergoing coronary angiography without angioplasty for acute coronary syndromesBRIEGER, David; SOLANKI, Vijay; GAYNOR, Maureen et al.The American journal of cardiology. 2002, Vol 89, Num 10, pp 1167-1170, issn 0002-9149Article

Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patientsHINGORANI, Anil; GRAMSE, Carol; ASCHER, Enrico et al.Journal of vascular surgery. 2002, Vol 36, Num 2, pp 341-345, issn 0741-5214Conference Paper

Does prior administration of enoxaparin influence the effects of levobupivacaine on blood clotting? Assessment using the thrombelastograph®LEONARD, S. A; LYDON, A; WALSH, M et al.British Journal of Anaesthesia. 2001, Vol 86, Num 6, pp 808-813, issn 0007-0912Article

Fractionation of low-molecular-mass heparin by centrifugal partition chromatography in the ion-exchange displacement modeINTES, Olivier; RENAULT, Jean-Hugues; SINQUIN, C et al.Journal of chromatography. 2001, Vol 918, Num 1, pp 47-57, issn 0021-9673Article

Absence of transplacental passage of the low molecular weight heparin enoxaparinDIMITRAKAKIS, Constantine; PAPAGEORGIOU, Panayiotis; PAPAGEORGIOU, Loannis et al.Haemostasis. 2000, Vol 30, Num 5, pp 243-248, issn 0301-0147Article